DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Triptorelin 3.75 MG Injection|PROCEDURE: Transvaginal oocyte retrieval|DRUG: Triptorelin Injection
Sponsor: Universitair Ziekenhuis Brussel
Collaborators: Universitaire Ziekenhuizen KU Leuven